Trials and tribulations of meta‐analyzing procedure‐related risks of amniocentesis and chorionic villus sampling
Authors:
- 22 May 2019
- journal article
- editorial
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 54 (4) , 437-441
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pregnancy outcome following mid-trimester amniocentesisJournal of Obstetrics and Gynaecology, 2012
- Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus samplingPrenatal Diagnosis, 2011
- Fetal loss rate after chorionic villus sampling and amniocentesis: an 11‐year national registry studyUltrasound in Obstetrics & Gynecology, 2009
- Evaluating the Rate and Risk Factors for Fetal Loss After Chorionic Villus SamplingObstetrics & Gynecology, 2008
- Miscarriage risk from amniocentesis performed for abnormal maternal serum screeningAmerican Journal of Obstetrics and Gynecology, 2007
- Pregnancy Loss Rates After Midtrimester AmniocentesisObstetrics & Gynecology, 2006
- Risk factors for procedure‐related fetal losses after mid‐trimester genetic amniocentesisPrenatal Diagnosis, 2006
- Risk of amniocentesis in women screened positive for Down syndrome with second trimester maternal serum markersPrenatal Diagnosis, 2002
- Medical Research Council European Trial of chorion villus samplingThe Lancet, 1991
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986